The many interactions between the innate immune system and the response to radiation

Cancer Letters

Volumn 368, Issue 2, 2015, Pages 173-178

  Candéias, Serge M ^a,b,c   Testard, Isabelle ^a,b,c  

^a CEA GRENOBLE   (France)

^b CNRS   (France)

^c UNIV GRENOBLE ALPES   (France)

Author keywords

Inflammation; Innate immune system; Radiation response

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; PROTEIN P53; AUTACOID;

APOPTOSIS; CELL TRANSFORMATION; CYTOSOL; DNA DAMAGE; DOWN REGULATION; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; IONIZING RADIATION; MACROPHAGE; MOLECULAR RECOGNITION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION RESPONSE; SENESCENCE; SHORT SURVEY; SIGNAL TRANSDUCTION; ANIMAL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; RADIATION INJURY;

ANIMALS; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS; RADIATION INJURIES; SIGNAL TRANSDUCTION;

EID: 84941877893     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.02.007     Document Type: Review

References (91)

1. Jackson S.P., Bartek J. The DNA-damage response in human biology and disease. Nature 2009, 461:1071-1078.
2. Medzhitov R., Janeway C.A. Decoding the patterns of self and nonself by the innate immune system. Science 2002, 296:298-300.
3. Paterson H.M., Murphy T.J., Purcell E.J., Shelley O., Kriynovich S.J., Lien E., et al. Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J. Immunol 2003, 171:1473-1483.
4. Dostert C., Petrilli V., Van Bruggen R., Steele C., Mossman B.T., Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677.
5. Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol 2008, 9:847-856.
6. Cheda A., Nowosielska E.M., Wrembel-Wargocka J., Janiak M.K. Production of cytokines by peritoneal macrophages and splenocytes after exposures of mice to low doses of X-rays. Radiat. Environ. Biophys 2008, 47:275-283.
7. Liu S.Z., Jin S.Z., Liu X.D., Sun Y.M. Role of CD28/B7 costimulation and IL-12/IL-10 interaction in the radiation-induced immune changes. BMC Immunol 2001, 2:8.
8. Meeran S.M., Punathil T., Katiyar S.K. IL-12 deficiency exacerbates inflammatory responses in UV-irradiated skin and skin tumors. J. Invest. Dermatol 2008, 128:2716-2727.
9. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol 2010, 10:826-837.
10. Rock K.L., Latz E., Ontiveros F., Kono H. The sterile inflammatory response. Annu. Rev. Immunol 2010, 28:321-342.
11. Wallin R.P., Lundqvist A., More S.H., von Bonin A., Kiessling R., Ljunggren H.G. Heat-shock proteins as activators of the innate immune system. Trends Immunol 2002, 23:130-135.
12. Galluzzi L., Bravo-San Pedro J.M., Vitale I., Aaronson S.A., Abrams J.M., Adam D., et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ 2014, 22:58-73.
13. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat. Rev. Immunol 2008, 8:279-289.
14. Li M., Carpio D.F., Zheng Y., Bruzzo P., Singh V., Ouaaz F., et al. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol 2001, 166:7128-7135.
15. Shakhov A.N., Singh V.K., Bone F., Cheney A., Kononov Y., Krasnov P., et al. Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2). PLoS ONE 2012, 7:e33044.
16. Salkowski C.A., Neta R., Wynn T.A., Strassmann G., van Rooijen N., Vogel S.N. Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotection. J. Immunol 1995, 155:3168-3179.
17. Liu C., Zhang C., Mitchel R.E., Cui J., Lin J., Yang Y., et al. A critical role of toll-like receptor 4 (TLR4) and its' in vivo ligands in basal radio-resistance. Cell Death Dis 2013, 4:e649.
18. Vijay-Kumar M., Aitken J.D., Sanders C.J., Frias A., Sloane V.M., Xu J., et al. Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. J. Immunol 2008, 180:8280-8285.
19. Burdelya L.G., Krivokrysenko V.I., Tallant T.C., Strom E., Gleiberman A.S., Gupta D., et al. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 2008, 320:226-230.
20. Saha S., Bhanja P., Liu L., Alfieri A.A., Yu D., Kandimalla E.R., et al. TLR9 agonist protects mice from radiation-induced gastrointestinal syndrome. PLoS ONE 2012, 7:e29357.
21. Neta R., Douches S., Oppenheim J.J. Interleukin 1 is a radioprotector. J. Immunol 1986, 136:2483-2485.
22. Neta R., Oppenheim J.J. Cytokines in therapy of radiation injury. Blood 1988, 72:1093-1095.
23. Neta R., Oppenheim J.J., Schreiber R.D., Chizzonite R., Ledney G.D., MacVittie T.J. Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor beta) in natural and lipopolysaccharide-enhanced radioresistance. J. Exp. Med 1991, 173:1177-1182.
24. Inagaki-Ohara K., Yada S., Takamura N., Reaves M., Yu X., Liu E., et al. p53-dependent radiation-induced crypt intestinal epithelial cells apoptosis is mediated in part through TNF-TNFR1 system. Oncogene 2001, 20:812-818.
25. Riehl T.E., Newberry R.D., Lorenz R.G., Stenson W.F. TNFR1 mediates the radioprotective effects of lipopolysaccharide in the mouse intestine. Am. J. Physiol. Gastrointest. Liver Physiol 2004, 286:G166-G173.
26. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol 2010, 11:373-384.
27. Lebre M.C., van der Aar A.M., van Baarsen L., van Capel T.M., Schuitemaker J.H., Kapsenberg M.L., et al. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J. Invest. Dermatol 2007, 127:331-341.
28. Nestle F.O., Di Meglio P., Qin J.Z., Nickoloff B.J. Skin immune sentinels in health and disease. Nat. Rev. Immunol 2009, 9:679-691.
29. Brickey W.J., Neuringer I.P., Walton W., Hua X., Wang E.Y., Jha S., et al. MyD88 provides a protective role in long-term radiation-induced lung injury. Int. J. Radiat. Biol 2012, 88:335-347.
30. Eldering E., Spek C.A., Aberson H.L., Grummels A., Derks I.A., de Vos A.F., et al. Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways. Nucleic Acids Res 2003, 31:e153.
31. Merad M., Sathe P., Helft J., Miller J., Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol 2013, 31:563-604.
32. Barbalat R., Lau L., Locksley R.M., Barton G.M. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat. Immunol 2009, 10:1200-1207.
33. Krivokrysenko V.I., Shakhov A.N., Singh V.K., Bone F., Kononov Y., Shyshynova I., et al. Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasure. J. Pharmacol. Exp. Ther 2012, 343:497-508.
34. Neta R., Oppenheim J.J., Douches S.D. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol 1988, 140:108-111.
35. Neta R., Perlstein R., Vogel S.N., Ledney G.D., Abrams J. Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor. J. Exp. Med 1992, 175:689-694.
36. Chatzinikolaou G., Karakasilioti I., Garinis G.A. DNA damage and innate immunity: links and trade-offs. Trends Immunol 2014, 35:429-435.
37. Holm C.K., Paludan S.R., Fitzgerald K.A. DNA recognition in immunity and disease. Curr. Opin. Immunol 2013, 25:13-18.
38. Paludan S.R., Bowie A.G. Immune sensing of DNA. Immunity 2013, 38:870-880.
39. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
40. Barrat F.J., Meeker T., Gregorio J., Chan J.H., Uematsu S., Akira S., et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med 2005, 202:1131-1139.
41. Fernandes-Alnemri T., Yu J.W., Datta P., Wu J., Alnemri E.S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009, 458:509-513.
42. Rathinam V.A., Jiang Z., Waggoner S.N., Sharma S., Cole L.E., Waggoner L., et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol 2010, 11:395-402.
43. Roth S., Rottach A., Lotz-Havla A.S., Laux V., Muschaweckh A., Gersting S.W., et al. Rad50-CARD9 interactions link cytosolic DNA sensing to IL-1beta production. Nat. Immunol 2014, 15:538-545.
44. Lindahl T., Barnes D.E., Yang Y.G., Robins P. Biochemical properties of mammalian TREX1 and its association with DNA replication and inherited inflammatory disease. Biochem. Soc. Trans 2009, 37:535-538.
45. Ahn J., Ruiz P., Barber G.N. Intrinsic self-DNA triggers inflammatory disease dependent on STING. J. Immunol 2014, 193:4634-4642.
46. Morita M., Stamp G., Robins P., Dulic A., Rosewell I., Hrivnak G., et al. Gene-targeted mice lacking the Trex1 (DNase III) 3'→5' DNA exonuclease develop inflammatory myocarditis. Mol. Cell. Biol 2004, 24:6719-6727.
47. Stetson D.B., Ko J.S., Heidmann T., Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598.
48. Lebon P., Badoual J., Ponsot G., Goutieres F., Hemeury-Cukier F., Aicardi J. Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy. J. Neurol. Sci 1988, 84:201-208.
49. de Silva U., Choudhury S., Bailey S.L., Harvey S., Perrino F.W., Hollis T. The crystal structure of TREX1 explains the 3' nucleotide specificity and reveals a polyproline II helix for protein partnering. J. Biol. Chem 2007, 282:10537-10543.
50. Gehrke N., Mertens C., Zillinger T., Wenzel J., Bald T., Zahn S., et al. Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing. Immunity 2013, 39:482-495.
51. Sirois C.M., Jin T., Miller A.L., Bertheloot D., Nakamura H., Horvath G.L., et al. RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA. J. Exp. Med 2013, 210:2447-2463.
52. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med 2000, 192:565-570.
53. Sims G.P., Rowe D.C., Rietdijk S.T., Herbst R., Coyle A.J. HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol 2010, 28:367-388.
54. Yanai H., Ban T., Wang Z., Choi M.K., Kawamura T., Negishi H., et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 2009, 462:99-103.
55. Loo Y.M., Gale M. Immune signaling by RIG-I-like receptors. Immunity 2011, 34:680-692.
56. Schlee M. Master sensors of pathogenic RNA - RIG-I like receptors. Immunobiology 2013, 218:1322-1335.
57. Hagmann C.A., Herzner A.M., Abdullah Z., Zillinger T., Jakobs C., Schuberth C., et al. RIG-I detects triphosphorylated RNA of Listeria monocytogenes during infection in non-immune cells. PLoS ONE 2013, 8:e62872.
58. Bernard J.J., Cowing-Zitron C., Nakatsuji T., Muehleisen B., Muto J., Borkowski A.W., et al. Ultraviolet radiation damages self noncoding RNA and is detected by TLR3. Nat. Med 2012, 18:1286-1290.
59. Cheng G. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy. Adv. Drug Deliv. Rev 2014, 81C:75-93.
60. van den Boorn J.G., Dassler J., Coch C., Schlee M., Hartmann G. Exosomes as nucleic acid nanocarriers. Adv. Drug Deliv. Rev 2013, 65:331-335.
61. Robbins P.D., Morelli A.E. Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol 2014, 14:195-208.
62. Al-Mayah A.H., Irons S.L., Pink R.C., Carter D.R., Kadhim M.A. Possible role of exosomes containing RNA in mediating nontargeted effect of ionizing radiation. Radiat. Res 2012, 177:539-545.
63. Jella K.K., Rani S., O'Driscoll L., McClean B., Byrne H.J., Lyng F.M. Exosomes are involved in mediating radiation induced bystander signaling in human keratinocyte cells. Radiat. Res 2014, 181:138-145.
64. Kondo T., Kobayashi J., Saitoh T., Maruyama K., Ishii K.J., Barber G.N., et al. DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:2969-2974.
65. Lavin M.F., Kozlov S. ATM activation and DNA damage response. Cell Cycle 2007, 6:931-942.
66. Stracker T.H., Roig I., Knobel P.A., Marjanovic M. The ATM signaling network in development and disease. Front. Genet 2013, 4:37.
67. Gottlieb T.M., Jackson S.P. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell 1993, 72:131-142.
68. Ferguson B.J., Mansur D.S., Peters N.E., Ren H., Smith G.L. DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. eLife 2012, 1:e00047.
69. Zhang X., Brann T.W., Zhou M., Yang J., Oguariri R.M., Lidie K.B., et al. Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN. J. Immunol 2011, 186:4541-4545.
70. Costantini S., Woodbine L., Andreoli L., Jeggo P.A., Vindigni A. Interaction of the Ku heterodimer with the DNA ligase IV/Xrcc4 complex and its regulation by DNA-PK. DNA Repair (Amst) 2007, 6:712-722.
71. Weterings E., Chen D.J. DNA-dependent protein kinase in nonhomologous end joining: a lock with multiple keys?. J. Cell Biol 2007, 179:183-186.
72. Block W.D., Yu Y., Merkle D., Gifford J.L., Ding Q., Meek K., et al. Autophosphorylation-dependent remodeling of the DNA-dependent protein kinase catalytic subunit regulates ligation of DNA ends. Nucleic Acids Res 2004, 32:4351-4357.
73. Blunt T., Finnie N.J., Taccioli G.E., Smith G.C., Demengeot J., Gottlieb T.M., et al. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 1995, 80:813-823.
74. Bosma G.C., Custer R.P., Bosma M.J. A severe combined immunodeficiency mutation in the mouse. Nature 1983, 301:527-530.
75. Jung M., Kondratyev A., Lee S.A., Dimtchev A., Dritschilo A. ATM gene product phosphorylates I kappa B-alpha. Cancer Res 1997, 57:24-27.
76. Jung M., Lee S.A., Zhang Y., Dritschilo A. Regulation of p53 in response to ionizing radiation in ataxia telangiectasia fibroblasts. Int. J. Radiat. Oncol. Biol. Phys 1997, 37:417-422.
77. Lee S.J., Dimtchev A., Lavin M.F., Dritschilo A., Jung M. A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-kappaB. Oncogene 1998, 17:1821-1826.
78. Piret B., Schoonbroodt S., Piette J. The ATM protein is required for sustained activation of NF-kappaB following DNA damage. Oncogene 1999, 18:2261-2271.
79. Sabatel H., Di Valentin E., Gloire G., Dequiedt F., Piette J., Habraken Y. Phosphorylation of p65(RelA) on Ser(547) by ATM represses NF-kappaB-dependent transcription of specific genes after genotoxic stress. PLoS ONE 2012, 7:e38246.
80. Wu Z.H., Shi Y., Tibbetts R.S., Miyamoto S. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 2006, 311:1141-1146.
81. Beckerman R., Prives C. Transcriptional regulation by p53. Cold Spring Harb. Perspect. Biol 2010, 2:a000935.
82. Sengupta S., Harris C.C. p53: traffic cop at the crossroads of DNA repair and recombination. Nat. Rev. Mol. Cell Biol 2005, 6:44-55.
83. Menendez D., Shatz M., Azzam K., Garantziotis S., Fessler M.B., Resnick M.A. The Toll-like receptor gene family is integrated into human DNA damage and p53 networks. PLoS Genet 2011, 7:e1001360.
84. Vassilev L.T., Vu B.T., Graves B., Carvajal D., Podlaski F., Filipovic Z., et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004, 303:844-848.
85. Lowe J.M., Menendez D., Bushel P.R., Shatz M., Kirk E.L., Troester M.A., et al. p53 and NF-kappaB coregulate proinflammatory gene responses in human macrophages. Cancer Res 2014, 74:2182-2192.
86. El-Saghire H., Thierens H., Monsieurs P., Michaux A., Vandevoorde C., Baatout S. Gene set enrichment analysis highlights different gene expression profiles in whole blood samples X-irradiated with low and high doses. Int. J. Radiat. Biol 2013, 89:628-638.
87. El-Saghire H., Michaux A., Thierens H., Baatout S. Low doses of ionizing radiation induce immune-stimulatory responses in isolated human primary monocytes. Int. J. Mol. Med 2013, 32:1407-1414.
88. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol 2005, 5:953-964.
89. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol 2011, 11:723-737.
90. Serhan C.N., Brain S.D., Buckley C.D., Gilroy D.W., Haslett C., O'Neill L.A., et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 2007, 21:325-332.
91. Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140:871-882.